生物可吸收支架市场规模、份额、成长分析（按产品类型、吸收率、应用、地区划分）- 产业预测，2025 年至 2032 年

2023 年生物可吸收支架市场规模价值 25.6 亿美元，预计将从 2024 年的 27.9 亿美元成长到 2032 年的 55.1 亿美元，预测期内（2025-2032 年）的复合年增长率为 8.9%。

受人口老化和心血管疾病发病率上升的推动，全球生物可吸收支架市场预计将显着增长。冠状动脉疾病的增加导致经经皮冠状动脉介入治疗 (PCI) 手术的增加以及患者和医疗保健提供者对生物可吸收支架的采用增加。技术进步和向微创治疗的转变进一步推动了市场扩张。促进创新的发展措施和有利的法规正在促进生物可吸收支架的发展。然而，手术成本高以及与这些支架相关的潜在风险等挑战可能会阻碍其成长。总体而言，人口变化、技术进步和政府支持措施将在塑造市场未来发展轨迹方面发挥关键作用。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 次要和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024 年）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 案例研究
• 监管格局

生物可吸收支架市场规模（依产品类型）

• 市场概况
• 聚合物基生物可吸收支架
• 金属基生物可吸收支架

生物可吸收支架市场规模（依吸收率）

• 市场概况
• 慢吸收支架
• 快速吸收支架

生物可吸收支架市场规模（依聚合物基生物可吸收支架划分）

• 市场概况
• 聚乳酸-乙醇酸支架
• Polyglycolic支架
• 聚（L-乳酸）支架
• 其他生物分解性聚合物支架

生物可吸收支架市场规模（依金属基生物可吸收支架划分）

• 市场概况
• 镁基支架
• 铁基支架
• 锌基支架
• 其他金属基生物可吸收支架

生物可吸收支架市场规模（依应用）

• 市场概况
• 冠状动脉疾病
• 周边动脉疾病

生物可吸收支架市场规模

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲国家
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前 5 家公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采用的策略
• 近期市场趋势
• 公司市场占有率分析（2024 年）
• 主要企业简介
  • 公司详细信息
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Boston Scientific Corporation（USA）
• Arterius Limited（UK）
• Kyoto Medical Planning Co., Ltd.（Japan）
• Terumo Corporation（Japan）
• Elixir Medical Corporation（USA）
• Abbott Laboratories Inc.（USA）
• Amaranth Medical（USA）
• Biotronik（Germany）
• Meril Life Sciences Pvt. Ltd.（India）
• Reva Medical（USA）
• Svelte Medical Systems（USA）
• Lepu Medical Technology Co., Ltd.（China）
• Medtronic plc（Ireland）
• B. Braun Melsungen AG（Germany）
• MicroPort Scientific Corporation（China）
• Cardionovum GmbH（Germany）
• Biotronik SE & Co. KG（Germany）
• ICON Interventional Systems（USA）
• Arterial Remodeling Technologies（France）
• Elixir Medical Corporation（USA）

结论和建议

Bioabsorbable Stents Market size was valued at USD 2.56 billion in 2023 and is poised to grow from USD 2.79 billion in 2024 to USD 5.51 billion by 2032, growing at a CAGR of 8.9% during the forecast period (2025-2032).

The global bioabsorbable stents market is poised for significant growth driven by an aging population and escalating cardiovascular disease prevalence. The rise in coronary artery disease has led to an uptick in percutaneous coronary intervention (PCI) procedures, amplifying the adoption of bioabsorbable stents by both patients and healthcare providers. Technological advancements and a shift towards minimally invasive treatments further boost market expansion. Government initiatives promoting innovation and favorable regulations enhance the development of bioabsorbable stents. However, challenges such as the high cost of procedures and potential risks associated with these stents could impede growth. Overall, demographic shifts, technological progress, and supportive government measures will play crucial roles in shaping the market's future trajectory.

Top-down and bottom-up approaches were used to estimate and validate the size of the Bioabsorbable Stents market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Bioabsorbable Stents Market Segments Analysis

Global Bioabsorbable Stents Market is segmented by Product Type, Absorption Rate, Polymer-Based Bioabsorbable Stents, Metal-Based Bioabsorbable Stents, Application and region. Based on Product Type, the market is segmented into Polymer-Based Bioabsorbable Stents and Metal-Based Bioabsorbable Stents. Based on Absorption Rate, the market is segmented into Slow-Absorption Stents and Fast-Absorption Stents. Based on Polymer-Based Bioabsorbable Stents, the market is segmented into PLGA (Poly (Lactic-Co-Glycolic Acid)) Stents, PGA (Polyglycolic Acid) Stents, PLLA (Poly (L-Lactic Acid)) Stents and Other Biodegradable Polymer Stents. Based on Metal-Based Bioabsorbable Stents, the market is segmented into Magnesium-Based Stents, Iron-Based Stents, Zinc-Based Stents and Other Metal-Based Bioabsorbable Stents. Based on Application, the market is segmented into Coronary Artery Diseases and Peripheral Artery Diseases. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Bioabsorbable Stents Market

The Bioabsorbable Stents market is significantly driven by advancements in design and technology, which have accelerated the treatment of coronary artery disease with biodegradable stents. These innovative stents are crafted from biodegradable polymers that safely dissolve after fulfilling their purpose, enhancing patient outcomes. Research by the U.S. FDA has highlighted the potential of these stents to mitigate late-stage complications, such as stent thrombosis. As a result, there is an increased patient acceptance and utilization, fostering wider market adoption and positioning bioabsorbable stents as a promising solution in cardiovascular care, effectively addressing a critical healthcare need for safer and more effective treatments.

Restraints in the Bioabsorbable Stents Market

The bioabsorbable stents market faces significant challenges due to concerns surrounding the long-term efficacy and safety of these devices. Healthcare providers remain skeptical, particularly following complications linked to several first-generation models, such as late stent thrombosis and restenosis, which have cast doubts on their clinical performance. These issues have negatively impacted market confidence, leading clinicians to advocate for more extensive clinical trials and the development of improved device designs. To regain trust in bioabsorbable stent technology, it is essential to establish enhanced safety profiles and provide comprehensive long-term data demonstrating their reliability and effectiveness in patient care.

Market Trends of the Bioabsorbable Stents Market

The bioabsorbable stents market is experiencing a significant trend towards the development of innovative materials aimed at enhancing clinical outcomes. Researchers are focusing on creating advanced composite materials that provide superior biocompatibility, increased mechanical strength, and optimized degradation rates. These improvements are designed to address the limitations of existing stent materials, ultimately leading to better patient outcomes and performance. This market shift highlights a commitment to enhancing the durability and long-term efficacy of bioabsorbable stents, thereby minimizing complications and bolstering the overall efficacy of cardiac interventions. As a result, growth in this segment is expected to accelerate significantly in the coming years.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape

Global Bioabsorbable Stents Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Polymer-Based Bioabsorbable Stents
• Metal-Based Bioabsorbable Stents

Global Bioabsorbable Stents Market Size by Absorption Rate & CAGR (2025-2032)

• Market Overview
• Slow-Absorption Stents
• Fast-Absorption Stents

Global Bioabsorbable Stents Market Size by Polymer-Based Bioabsorbable Stents & CAGR (2025-2032)

• Market Overview
• PLGA (Poly (Lactic-Co-Glycolic Acid)) Stents
• PGA (Polyglycolic Acid) Stents
• PLLA (Poly (L-Lactic Acid)) Stents
• Other Biodegradable Polymer Stents

Global Bioabsorbable Stents Market Size by Metal-Based Bioabsorbable Stents & CAGR (2025-2032)

• Market Overview
• Magnesium-Based Stents
• Iron-Based Stents
• Zinc-Based Stents
• Other Metal-Based Bioabsorbable Stents

Global Bioabsorbable Stents Market Size by Application & CAGR (2025-2032)

• Market Overview
• Coronary Artery Diseases
• Peripheral Artery Diseases

Global Bioabsorbable Stents Market Size & CAGR (2025-2032)

• North America (Product Type, Absorption Rate, Polymer-Based Bioabsorbable Stents, Metal-Based Bioabsorbable Stents, Application)
  • US
  • Canada
• Europe (Product Type, Absorption Rate, Polymer-Based Bioabsorbable Stents, Metal-Based Bioabsorbable Stents, Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Absorption Rate, Polymer-Based Bioabsorbable Stents, Metal-Based Bioabsorbable Stents, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Absorption Rate, Polymer-Based Bioabsorbable Stents, Metal-Based Bioabsorbable Stents, Application)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Absorption Rate, Polymer-Based Bioabsorbable Stents, Metal-Based Bioabsorbable Stents, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Arterius Limited (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kyoto Medical Planning Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elixir Medical Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amaranth Medical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotronik (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meril Life Sciences Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Reva Medical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Svelte Medical Systems (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lepu Medical Technology Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroPort Scientific Corporation (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardionovum GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotronik SE & Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ICON Interventional Systems (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Arterial Remodeling Technologies (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elixir Medical Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations